Brief: MGC Pharmaceuticals Receives Permission For First Import Of Psilocybin
31/07/2023 07:40
July 31 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* MGC PHARMACEUTICALS - PERMISSION FOR FIRST IMPORT OF PSILOCYBIN
Source text for Eikon: ID:nRSe6410Ha
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program